References
- 1. Tokito T, Azuma K, Yamada K, Naito Y, Matsuo N, Ishii H, et al. Prognostic Value of Serum Tumor Markers in Patients With Stage III NSCLC Treated With Chemoradiotherapy. In Vivo. 2019;33(3):889-95. DOI: 10.21873/invivo.1155510.21873/invivo.11555655988531028213
- 2. Chen Z, Wang Y, Fang M. Analysis of tumor markers in pleural effusion and serum to verify the correlations between serum tumor markers and tumor size, TNM stage of lung adenocarcinoma. Cancer Med. 2020;9(4):1392-99. DOI: 10.1002/cam4.280910.1002/cam4.2809701307031881123
- 3. Tetikkurt C, Yılmaz N, Tetikkurt S, Gundogdu Ş, Disci R. The value of exfoliative cell cytology in the diagnosis of exudative pleural effusions. Monaldi Arch Chest Dis. 2018;88(3):944. DOI: 10.4081/monaldi.2018.94410.4081/monaldi.2018.94430203633
- 4. Nithin KU, Sridhar MG, Srilatha K, Habebullah S. CA 125 is a better marker to differentiate endometrial cancer and abnormal uterine bleeding. Afr Health Sci. 2018;18(4):972-8. DOI: 10.4314/ahs.v18i4.1710.4314/ahs.v18i4.17635488730766562
- 5. Gomes TA, Campos EA, Yoshida A, Sarian LO, Andrade LALA, Derchain SF. Preoperative Differentiation of Benign and Malignant Non-epithelial Ovarian Tumors: Clinical Features and Tumor Markers. Rev Bras Ginecol Obstet. 2020;42(9):555-61. DOI: 10.1055/s-0040-171299310.1055/s-0040-171299332992358
- 6. Georgantzi K, Sköldenberg EG, Stridsberg M, Kogner P, Jakobson Å, Janson ET, et al. Chromogranin A and neuron-specific enolase in neuroblastoma: Correlation to stage and prognostic factors. Pediatr Hematol Oncol. 2018;35(2):156-65. DOI: 10.1080/08880018.2018.146408710.1080/08880018.2018.146408729737901
- 7. Qu T, Zhang J, Xu N, Liu B, Li M, Liu A, et al. Diagnostic value analysis of combined detection of Trx, CYFRA21-1 and SCCA in lung cancer. Oncol Lett. 2019;17(5):4293-8. DOI: 10.3892/ol.2019.1007310.3892/ol.2019.10073644433130944623
- 8. Yu RZ, Huang MT. [The Diagnostic Value of Tumor Markers Combined with Fiberoptic Bronchoscopic Brushing in Lung Carcinoma]. Labeled Immunoassays and Clinical Medicine. 2014;21:360-3.
- 9. Grunnet M, Sorensen JB. Carcinoembryonic antigen (CEA) as tumor marker in lung cancer. Lung Cancer. 2012;76(2):138-43. DOI: 10.1016/j.lung-can.2011.11.012
- 10. Villalobos P, Wistuba II. Lung Cancer Biomarkers. Hematol Oncol Clin North Am. 2017;31(1):13-29. DOI: 10.1016/j.hoc.2016.08.00610.1016/j.hoc.2016.08.006513780427912828
- 11. Duffy MJ, Sturgeon C, Lamerz R, Haglund C, Holubec VL, Klapdor R, et al. Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. Ann Oncol. 2010;21(3):441-7. DOI: 10.1093/annonc/mdp33210.1093/annonc/mdp33219690057
- 12. O’Leary PC, Feddema PH, Michelangeli VP, Leedman PJ, Chew GT, Knuiman M, et al. Investigations of thyroid hormones and antibodies based on a community health survey: the Busselton thyroid study. Clin Endocrinol (Oxf). 2006;64(1):97-104. DOI: 10.1111/j.1365-2265.2005.02424.x10.1111/j.1365-2265.2005.02424.x16402936
- 13. Ferreiro L, Toubes ME, Valdés L. [Contribution of pleural fluid analysis to the diagnosis of pleural effusion]. Med Clin (Barc). 2015;145(4):171-7. DOI: 10.1016/j. medcli.2014.08.005
- 14. Duffy MJ, O’Byrne K. Tissue and Blood Biomarkers in Lung Cancer: A Review. Adv Clin Chem. 2018;86:1-21. DOI: 10.1016/bs.acc.2018.05.00110.1016/bs.acc.2018.05.00130144837
- 15. Allama AM, Abou-Elela DH, Ibrahim IM. Pleural and serum markers for diagnosis of malignant pleural effusion. Asian Cardiovasc Thorac Ann. 2020;28(9):560-5. DOI: 10.1177/021849232094831110.1177/021849232094831132741198
- 16. Dal Bello MG, Filiberti RA, Alama A, Orengo AM, Mussap M, Coco S, et al. The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients. J Transl Med. 2019;17(1):74. DOI: 10.1186/s12967-019-1828-010.1186/s12967-019-1828-0640878430849967
- 17. Hao C, Zhang G, Zhang L. Serum CEA levels in 49 different types of cancer and noncancer diseases. Prog Mol Biol Transl Sci. 2019;162:213-27. DOI: 10.1016/bs.pmbts.2018.12.01110.1016/bs.pmbts.2018.12.01130905451
- 18. Osanyin GE, Okunade KS, Ayotunde Oluwole A. Association between serum CA125 levels in preeclampsia and its severity among women in Lagos, South-West Nigeria. Hypertens Pregnancy. 2018;37(2):93-7. DOI: 10.1080/10641955.2018.146066710.1080/10641955.2018.146066729718786
- 19. Chen C, Chen Q, Zhao Q, Liu M, Guo J. Value of Combined Detection of Serum CEA, CA72-4, CA19-9, CA15-3 and CA12-5 in the Diagnosis of Gastric Cancer. Ann Clin Lab Sci. 2017;47(3):260-3.
- 20. Wang B, He YJ, Tian YX, Yang RN, Zhu YR, Qiu H. Clinical utility of haptoglobin in combination with CEA, NSE and CYFRA21-1 for diagnosis of lung cancer. Asian Pac J Cancer Prev. 2014;15(22):9611-4. DOI: 10.7314/APJCP.2014.15.22.961110.7314/APJCP.2014.15.22.961125520076
- 21. Ren X, Zhang Y, Lyu Y, Jin B, Guo H, Wu J, et al. Lac-tate dehydrogenase and serum tumor markers for predicting metastatic status in geriatric patients with lung adenocarcinoma. Cancer Biomark. 2019;26(2):139-50. DOI: 10.3233/CBM-19020110.3233/CBM-19020131356196